Xiao; Xiaodong
Patent Applications and Registrations
Patent applications and USPTO patent grants for Xiao; Xiaodong.The latest application filed is for "anti-o1 antibodies and uses thereof".
- Xiao; Xiaodong - Gaithersburg MD
- XIAO; Xiaodong - Frederick MD
| Patent | Date |
|---|---|
| Anti-O2 antibodies and uses thereof Grant 11,447,542 - Wang , et al. September 20, 2 | 2022-09-20 |
| Anti-o1 Antibodies And Uses Thereof App 20220056113 - WANG; Qun ; et al. | 2022-02-24 |
| Anti-O1 antibodies and uses thereof Grant 11,117,956 - Wang , et al. September 14, 2 | 2021-09-14 |
| Anti-o2 Antibodies And Uses Thereof App 20210238263 - Wang; Qun ; et al. | 2021-08-05 |
| BCMA Monoclonal Antibody-Drug Conjugate App 20210214460 - KINNEER; Krista ; et al. | 2021-07-15 |
| BCMA monoclonal antibody-drug conjugate Grant 10,988,546 - Kinneer , et al. April 27, 2 | 2021-04-27 |
| Anti-o1 Antibodies And Uses Thereof App 20200231660 - Wang; Qun ; et al. | 2020-07-23 |
| Binding Molecules Specific For Il-21 And Uses Thereof App 20200164069 - Ettinger; Catherine ; et al. | 2020-05-28 |
| Antibodies specific for IL-21 and uses thereof Grant 10,588,969 - Ettinger , et al. | 2020-03-17 |
| Human monoclonal antibodies specific for CD22 Grant 10,494,435 - Dimitrov , et al. De | 2019-12-03 |
| Assay To Detect Human Dpp-4 App 20190352425 - CHANG; Chien-Ying ; et al. | 2019-11-21 |
| Assay to detect human DPP-4 Grant 10,351,630 - Chang , et al. July 16, 2 | 2019-07-16 |
| Mrka Polypeptides, Antibodies, And Uses Thereof App 20190062411 - WANG; Qun ; et al. | 2019-02-28 |
| BCMA Monoclonal Antibody-Drug Conjugate App 20190040152 - KINNEER; Krista ; et al. | 2019-02-07 |
| Binding Molecules Specific For Il-21 And Uses Thereof App 20180318416 - Ettinger; Catherine ; et al. | 2018-11-08 |
| Antibodies specific for IL-21 and uses thereof Grant 10,022,443 - Ettinger , et al. July 17, 2 | 2018-07-17 |
| Binding Molecules Specific For Il-21 And Uses Thereof App 20170173149 - Ettinger; Catherine ; et al. | 2017-06-22 |
| Human Monoclonal Antibodies Specific For Cd22 App 20170145097 - Dimitrov; Dimiter S. ; et al. | 2017-05-25 |
| Human monoclonal antibodies specific for CD22 Grant 9,598,492 - Dimitrov , et al. March 21, 2 | 2017-03-21 |
| MrkA Polypeptides, Antibodies, and Uses Thereof App 20170073397 - WANG; Qun ; et al. | 2017-03-16 |
| Assay To Detect Human Dpp-4 App 20160200832 - Chang; Chien-Ying ; et al. | 2016-07-14 |
| Human Monoclonal Antibodies Specific For Cd22 App 20160145338 - Dimitrov; Dimiter S. ; et al. | 2016-05-26 |
| Human monoclonal antibodies specific for CD22 Grant 9,279,019 - Dimitrov , et al. March 8, 2 | 2016-03-08 |
| Human monoclonal antibodies protective against bubonic plague Grant 8,722,046 - Amemiya , et al. May 13, 2 | 2014-05-13 |
| Human Monoclonal Antibodies Specific For Cd22 App 20130315921 - Dimitrov; Dimiter S. ; et al. | 2013-11-28 |
| Human monoclonal antibodies specific for CD22 Grant 8,591,889 - Dimitrov , et al. November 26, 2 | 2013-11-26 |
| Human Monoclonal Antibodies Protective Against Bubonic Plague App 20120114656 - Amemiya; Kei ; et al. | 2012-05-10 |
| Human Monoclonal Antibodies Specific For Cd22 App 20110020344 - Dimitrov; Dimiter S. ; et al. | 2011-01-27 |
| Soluble Fragments of The Sars-Cov Spike Glycoprotein App 20090304683 - Dimitrov; Dimiter S. ; et al. | 2009-12-10 |
| Soluble fragments of the SARS-CoV spike glycoprotein App 20060240515 - Dimitrov; Dimiter S. ; et al. | 2006-10-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 